FRMO CORP
FRMO
Bakkt Holdings
BKKT
Argo Blockchain
ARBK
SATO TECHNOLOGIES CORP
CCPUF
SAI TECH Global
SAI
Alto Neuroscience, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of psychiatric drugs. Its pipeline is composed of five clinical-stage assets which initially target depressive disorder and schizophrenia population. The company was founded by Amit Etkin, Dan Segal, and Wei Wu on March 25, 2019 and is headquartered in Mountain View, CA.